How much does liver disease affect the pharmacokinetics of adriamycin?
Eur J Cancer Clin Oncol
.
1985 Aug;21(8):893-5.
doi: 10.1016/0277-5379(85)90103-8.
Authors
S B Kaye
,
J Cummings
,
D J Kerr
PMID:
2995044
DOI:
10.1016/0277-5379(85)90103-8
No abstract available
MeSH terms
Carcinoma, Hepatocellular / metabolism
Doxorubicin / metabolism*
Humans
Kinetics
Liver / metabolism
Liver Diseases / metabolism*
Liver Neoplasms / metabolism
Substances
Doxorubicin